The report focuses on the High Content Screening market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the High Content Screening market.
Major Players in the High Content Screening market are:
GE Healthcare
Merck KGaA
Becton, Dickinson and Company
Perkinelmer Inc.
Thermo Fisher Scientific Inc.
Danaher Corporation
Biotek Instruments Inc.
Bio-Rad Laboratories Inc.
Yokogawa Electric Corporation
On the basis of types, the High Content Screening market is primarily split into:
Instruments
Consumables
Software
Services
Accessories
On the basis of applications, the market covers:
Target Identification and Validation
Primary Screening and Secondary Screening
Toxicity Studies
Compound Profiling
Other Applications
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global High Content Screening Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 High Content Screening Market Overview
1.1 Product Overview and Scope of High Content Screening Market
1.2 High Content Screening Market Segment by Type
1.2.1 Global High Content Screening Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global High Content Screening Market Segment by Application
1.3.1 High Content Screening Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global High Content Screening Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of High Content Screening (2017-2029)
1.5.1 Global High Content Screening Market Revenue Status and Outlook (2017-2029)
1.5.2 Global High Content Screening Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the High Content Screening Industry
1.7 Impact of Carbon Neutrality on the High Content Screening Industry
2 High Content Screening Market Upstream and Downstream Analysis
2.1 High Content Screening Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of High Content Screening Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 GE Healthcare
3.1.1 GE Healthcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 High Content Screening Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Merck KGaA
3.2.1 Merck KGaA Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 High Content Screening Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Becton, Dickinson and Company
3.3.1 Becton, Dickinson and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 High Content Screening Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Perkinelmer Inc.
3.4.1 Perkinelmer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 High Content Screening Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Thermo Fisher Scientific Inc.
3.5.1 Thermo Fisher Scientific Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 High Content Screening Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Danaher Corporation
3.6.1 Danaher Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 High Content Screening Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Biotek Instruments Inc.
3.7.1 Biotek Instruments Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 High Content Screening Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Bio-Rad Laboratories Inc.
3.8.1 Bio-Rad Laboratories Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 High Content Screening Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Yokogawa Electric Corporation
3.9.1 Yokogawa Electric Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 High Content Screening Market Performance (2017-2022)
3.9.4 Business Overview
4 Global High Content Screening Market Landscape by Player
4.1 Global High Content Screening Sales and Share by Player (2017-2022)
4.2 Global High Content Screening Revenue and Market Share by Player (2017-2022)
4.3 Global High Content Screening Average Price by Player (2017-2022)
4.4 Global High Content Screening Gross Margin by Player (2017-2022)
4.5 High Content Screening Market Competitive Situation and Trends
4.5.1 High Content Screening Market Concentration Rate
4.5.2 High Content Screening Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global High Content Screening Sales, Revenue, Price Trend by Type
5.1 Global High Content Screening Sales and Market Share by Type (2017-2022)
5.2 Global High Content Screening Revenue and Market Share by Type (2017-2022)
5.3 Global High Content Screening Price by Type (2017-2022)
5.4 Global High Content Screening Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global High Content Screening Sales, Revenue and Growth Rate of Instruments (2017-2022)
5.4.2 Global High Content Screening Sales, Revenue and Growth Rate of Consumables (2017-2022)
5.4.3 Global High Content Screening Sales, Revenue and Growth Rate of Software (2017-2022)
5.4.4 Global High Content Screening Sales, Revenue and Growth Rate of Services (2017-2022)
5.4.5 Global High Content Screening Sales, Revenue and Growth Rate of Accessories (2017-2022)
6 Global High Content Screening Market Analysis by Application
6.1 Global High Content Screening Consumption and Market Share by Application (2017-2022)
6.2 Global High Content Screening Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global High Content Screening Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global High Content Screening Consumption and Growth Rate of Target Identification and Validation (2017-2022)
6.3.2 Global High Content Screening Consumption and Growth Rate of Primary Screening and Secondary Screening (2017-2022)
6.3.3 Global High Content Screening Consumption and Growth Rate of Toxicity Studies (2017-2022)
6.3.4 Global High Content Screening Consumption and Growth Rate of Compound Profiling (2017-2022)
6.3.5 Global High Content Screening Consumption and Growth Rate of Other Applications (2017-2022)
7 Global High Content Screening Sales and Revenue Region Wise (2017-2022)
7.1 Global High Content Screening Sales and Market Share, Region Wise (2017-2022)
7.2 Global High Content Screening Revenue and Market Share, Region Wise (2017-2022)
7.3 Global High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa High Content Screening Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global High Content Screening Market Forecast (2022-2029)
8.1 Global High Content Screening Sales, Revenue Forecast (2022-2029)
8.1.1 Global High Content Screening Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global High Content Screening Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global High Content Screening Price and Trend Forecast (2022-2029)
8.2 Global High Content Screening Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.2 Europe High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.3 China High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.4 Japan High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.5 India High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America High Content Screening Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa High Content Screening Sales and Revenue Forecast (2022-2029)
8.3 Global High Content Screening Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global High Content Screening Revenue and Growth Rate of Instruments (2022-2029)
8.3.2 Global High Content Screening Revenue and Growth Rate of Consumables (2022-2029)
8.3.3 Global High Content Screening Revenue and Growth Rate of Software (2022-2029)
8.3.4 Global High Content Screening Revenue and Growth Rate of Services (2022-2029)
8.3.5 Global High Content Screening Revenue and Growth Rate of Accessories (2022-2029)
8.4 Global High Content Screening Consumption Forecast by Application (2022-2029)
8.4.1 Global High Content Screening Consumption Value and Growth Rate of Target Identification and Validation (2022-2029)
8.4.2 Global High Content Screening Consumption Value and Growth Rate of Primary Screening and Secondary Screening (2022-2029)
8.4.3 Global High Content Screening Consumption Value and Growth Rate of Toxicity Studies (2022-2029)
8.4.4 Global High Content Screening Consumption Value and Growth Rate of Compound Profiling (2022-2029)
8.4.5 Global High Content Screening Consumption Value and Growth Rate of Other Applications (2022-2029)
8.5 High Content Screening Market Forecast Under COVID-19
9 Industry Outlook
9.1 High Content Screening Market Drivers Analysis
9.2 High Content Screening Market Restraints and Challenges
9.3 High Content Screening Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 High Content Screening Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 High Content Screening Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on High Content Screening Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Drug Discovery Services Market by Process (Target Selection, Hit-to-lead), Type (Chemistry, Biology), Drug Type (Small Molecule, Biologics), Therapeutic Area (Oncology, Neurology, Infectious), End User (Pharma, Biotech, Academic) - Global Forecast to 2028
Published: 20-Mar-2023 Price: US 4950 Onwards Pages: 347
Growing R&D Expenditure by pharmaceutical and biopharmaceutical companies is expected to drive the market growth
The global Drug discovery services market is projected to reach USD 41.3 billion by 2028 from USD 20.6 billion in 2023, at a CAGR of 14.9% during the forecast period of 2023 to 2028. Growing R&D expenditure in pharma-biotech sector, increasing drug R&D pipeline and rising reliance on outsourcing, initiatives for research on rare diseases and orp......
Global Fragment-Based Drug Discovery Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 07-Mar-2023 Price: US 3260 Onwards Pages: 116
The Fragment-Based Drug Discovery market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Fragment-Based Drug Discovery industry, and breaks down according to the type, application, and consumption area of Fragment-Based Drug Discovery. The report also introduces players in the industry from the perspective of the industry chain an......
Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2016 - 2023
Published: 01-Mar-2023 Price: US 3995 Onwards Pages: 2500
The Global Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2016-2023 report.
The report provides a detailed understanding and analysis of how, why and on what terms companies enter discovery stage partnering deals. These deals are discovery stage whereby the licensee obtains a right or an option right to license the licensors product or technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
......
Global Botanical and Plant Derived Drugs Market Research Report 2023
Published: 07-Feb-2023 Price: US 2900 Onwards Pages: 88
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in vari......
Global Fragment-based Drug Discovery Market Research Report 2023
Published: 07-Feb-2023 Price: US 2900 Onwards Pages: 94
The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices.
Highlights
The global Fragment-based Drug Discovery market was valued at US$ 365.8 million in 2022 and is anticipated to reach US$ 533.8 million by 2029, witnessing a CAGR of 6.5% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while......
Global High Content Screening Market Research Report 2023
Published: 06-Feb-2023 Price: US 2900 Onwards Pages: 91
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
Global Fragment-Based Drug Discovery Market Research Report 2022 - Market Size, Current Insights and Development Trends
Published: 17-Jan-2023 Price: US 3450 Onwards Pages: 102
The report focuses on the Fragment-Based Drug Discovery market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream mar......
Global High Content Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Published: 15-Jan-2023 Price: US 3480 Onwards Pages: 102
High-content screening (HCS) or high-content analysis (HCA) (also known as cellomics), is a set of analytical techniques that is applied in genetic research and drug discovery processes in order to recognize elements such as peptides, small molecules, or genetic materials (such as RNAi) that have the potential to modify the phenotype of a cell in a certain manner. High-content screening employs a set of analytical procedures such as multi-parameter image processing, automated microscopy, fluores......
Global High Throughput Screening Market Research Report 2022 - Market Size, Current Insights and Development Trends
Published: 29-Nov-2022 Price: US 3450 Onwards Pages: 105
High throughput screening refers to the experimental method based on molecular and cellular levels, using microplate as an experimental tool carrier, performing the test process with an automated operating system, collecting experimental results data with sensitive and rapid detection instruments, and processing experiments with computer analysis. Data, testing tens of millions of samples at the same time, and supporting the running technical system with the corresponding database, it is charact......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
